US Chinese Anti-Cancer Association (USCACA) will present a special session on oncology drug R&D in China at the ChinaTrials Conference on Nov. 10 in Beijing. Featured speakers will include experts from Chinese Society for Clinical Oncology, China SFDA, large pharmaceutical companies, new upcoming China biotechnology companies, and CROs. Main theme of the session is "How to Transform China from a Cancer Drug R&D Participant to a Leader"? 

For more details about this special session, please see the full agenda at http://www.chinatrialsevent.com/agenda.php